US 12291576
Anti-CD45 antibodies and conjugates thereof
granted A61KA61K2039/505A61K38/12
Quick answer
US patent 12291576 (Anti-CD45 antibodies and conjugates thereof) held by Vor Biopharma Inc. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vor Biopharma Inc.
- Grant date
- Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K38/12, A61K47/6831, A61K47/6849